New-onset lone atrial fibrillation in pregnancy

Anugu, Viswajit Reddy; Nalluri, Nikhil; Asti, Deepak; Gaddam, Sainath; Vazzana, Thomas; Lafferty, James

doi:10.1177/1753944716644584

Cited by 13 publications

(4 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Verapamil, a non-dihydropyridine calcium channel blocker, was used in pregnant women, especially those with arrhythmia, in a few studies [89,90]. There is no sufficient data regarding its maternal and foetal side-effects.…”

Section: Antihypertensive Drug Treatmentmentioning

confidence: 99%

Management of hypertension in pregnancy — prevention, diagnosis, treatment and long-term prognosis. A position statement of the Polish Society of Hypertension, Polish Cardiac Society and Polish Society of Gynaecologists and Obstetricians

Prejbisz¹,

Dobrowolski²,

Kosiński³

et al. 2019

Arterial Hypertension

View full text Add to dashboard Cite

Disclaimer: The position statement represent the views of the authors and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their dating. The authors and societies are not responsible in the event of any contradiction, discrepancy, and/or ambiguity between the position statement and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the position statement fully into account when exercising their clinical judgment as well as in the determination and the implementation of preventive, diagnostic, or therapeutic medical strategies. 118 www.ah.viamedica.pl ABPM -ambulatory blood pressure monitoring ACE-I -angiotensin-converting enzyme inhibitor AF -atrial fibrillation AFI -amniotic fluid index AFL -atrial flutter AGA -appropriate for gestational age AHI -apnea hypopnea index AKI -acute kidney injury ALT -alanine transaminase ARB -angiotensin receptor blocker ARR -aldosterone-to-renin ratio AST -aspartate aminotransferase AT -atrial tachycardia BAV -bicuspid aortic valve BMI -body mass index BNP -B-nariuretic peptide BP -blood pressure Bpm -beats per minute BPP -biophysical profile CABG -coronary artery bypass graft CAD -coronary artery disease CKD -chronic kidney disease CNS -central nervous system CoA -coarctation of the aorta CPAP -continuous positive airway pressure CPR -cerebroplacental ratio CTG -cardiotocography CV -cardiovascular DBP -diastolic blood pressure DIC -disseminated intravascular coagulation DM -diabetes mellitus ECMO -extracorporeal membrane oxygenation ECG -electrocardiography EF -ejection fraction ESC -European Society of Cardiology ESH -European Society of Hypertension EVA -early vascular ageing FDA -Food and Drug Administration FHR -foetal heart rate FIGO -International Federation of Gynaecology and Obstetrics FMD -fibromuscular dysplasia FMF -Fetal Medicine Foundation FPS -frame per second GFR -glomerular filtration rate HELLP -hemolysis, elevated liver enzymes, low platelet countuterine growth restriction IVF -in vitro fertilisation LBBB -left bundle branch block LBW -low birth weight LDH -lactate dehydrogenase LQTS -long QT syndrome LVAD -left ventricular assist device LVEF -left ventricular ejection fraction MAP -mean arterial pressure MCA -middle cerebral artery MCS -mechanical circulatory support MDT -multidisciplinary team MRA -mineralocorticoids renceptor antagonist MRAs -mineralocorticoids renceptor antagonists MRI -magnetic resonance imaging NSTEMI -non-ST elevation myocardial infarction NT-BNP -N-terminal pro-BNP NTS -non-stress-test OGTT -oral glucose tolerance test OSA -obstructive sleep apnoea p.o. -per os PA -primary aldosteronism PAPP-A -pregnancy associated placental protein PCI -percutaneous coronary intervention PE -pre-eclampsia PI -pulsatility index PlGF -placental growth factor PPCM -peripartum cardiomyopathy PPGL -pheochromocytoma a...

show abstract

Section: Antihypertensive Drug Treatmentmentioning

confidence: 99%

Management of hypertension in pregnancy — prevention, diagnosis, treatment and long-term prognosis. A position statement of the Polish Society of Hypertension, Polish Cardiac Society and Polish Society of Gynaecologists and Obstetricians

Prejbisz¹,

Dobrowolski²,

Kosiński³

et al. 2019

Arterial Hypertension

View full text Add to dashboard Cite

show abstract

“…In the rare case of AF with no risk factors or signs of heart disease, anticoagulation may not be necessary. 1,14 SDM should be used when considering anticoagulation during pregnancy (Table 28). Some patients may be deemed at high risk for stroke, such as those with mitral stenosis, for which recommendations for anticoagulation in pregnancy are extrapolated from experience in managing VHD.…”

Section: Af and Specific Patient Groupsmentioning

confidence: 99%

2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Joglar,

Chung,

Armbruster

et al. 2024

Circulation

566

View full text Add to dashboard Cite

AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation” provides recommendations to guide clinicians in the treatment of patients with atrial fibrillation. METHODS A comprehensive literature search was conducted from May 12, 2022, to November 3, 2022, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. Additional relevant studies, published through November 2022, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate. STRUCTURE Atrial fibrillation is the most sustained common arrhythmia, and its incidence and prevalence are increasing in the United States and globally. Recommendations from the “2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation” and the “2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation” have been updated with new evidence to guide clinicians. In addition, new recommendations addressing atrial fibrillation and thromboembolic risk assessment, anticoagulation, left atrial appendage occlusion, atrial fibrillation catheter or surgical ablation, and risk factor modification and atrial fibrillation prevention have been developed.

show abstract

“…While most AF in pregnancy are the result of an underlying cardiac arrhythmia or structural abnormality, some women develop new-onset AF during pregnancy [21]. Their presentation and outcomes have not been previously described [22].…”

Section: Discussionmentioning

confidence: 99%

Clinical analysis of atrial fibrillation in pregnant women

Zhang,

Yang

et al. 2020

Clin. Exp. Obstet. Gynecol.

View full text Add to dashboard Cite

Objective: To analyze the clinical characteristics and risk factors for the major adverse cardiovascular events (MACEs) of atrial fibrillation (AF) in pregnant women. Materials and Methods: A retrospective analysis was performed on 35 pregnant women with AF, who were treated at Beijing Anzhen Hospital, Capital Medical University, from January 2004 to May 2017. All pregnancies were recorded. Chi-squared test analysis was performed to determine the correlation between clinical factors and MACEs. Results: There were 11 cases of MACEs (31.4%), including 10 cases of heart failure (HF) and 1 case of cerebral infarction. We found 7 clinical factors with a clear correlation with the occurrence of MACEs during pregnancy: a medical history of heart operation (P = 0.0011) and AF before pregnancy (P = 0.0281), New York Heart Association (NYHA) class (P < 0.0001), a left ventricular ejection fraction (LVEF) ≤ 50% (P = 0.0055), and a delivery time < 37 weeks (P = 0.0037). The AF subtype and delivery mode have no correlation with MACEs. Conclusion: AF in pregnant women is dangerous for pregnancy and delivery, multidisciplinary management of obstetricians, cardiologists, and neonatologists are crucial for these patients throughout pregnancy.

show abstract

New-onset lone atrial fibrillation in pregnancy

Cited by 13 publications

References 9 publications

Management of hypertension in pregnancy — prevention, diagnosis, treatment and long-term prognosis. A position statement of the Polish Society of Hypertension, Polish Cardiac Society and Polish Society of Gynaecologists and Obstetricians

Management of hypertension in pregnancy — prevention, diagnosis, treatment and long-term prognosis. A position statement of the Polish Society of Hypertension, Polish Cardiac Society and Polish Society of Gynaecologists and Obstetricians

2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Clinical analysis of atrial fibrillation in pregnant women

Contact Info

Product

Resources

About